Loading Events

« All Events

  • This event has passed.

Drug Development Considerations for the Prevention of Healthcare Associated Infections

August 30, 2022 @ 8:30 am - 5:00 pm EDT

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures, speaker slides, workshop recording, and transcript—will be posted here shortly before and/or after the completion of the workshop.

  • The current state of development of pathogen-directed products used to prevent healthcare-associated infections (HAIs).
  • Evidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens.
  • Antimicrobial resistance threats as potential targets for decolonization and pathogen reduction.
  • Challenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections.

This meeting will be held in virtual format only. Registration is required for online attendance and will be available until 12 p.m. EDT on August 29, 2022.


August 30, 2022
8:30 am - 5:00 pm EDT
Event Categories:


Centers for Disease Control and Prevention (CDC)
Food and Drug Administration (FDA)